Literature DB >> 3408020

Three-year follow-up of risk factors correlated with new atherothrombotic brain infarction in 708 elderly patients.

W S Aronow1, H Gutstein, N H Lee, M Edwards.   

Abstract

A prospective study correlated cigarette smoking, systolic or diastolic hypertension, diabetes mellitus, hypercholesterolemia, low serum high-density lipoprotein cholesterol, hypertriglyceridemia, and obesity with development of new atherothrombotic brain infarction in 192 elderly men and 516 elderly women. Mean follow-up was 36 +/- 6 months (range 19-39). New atherothrombotic brain infarction occurred in 24 of 192 men (13%) and in 63 of 516 women (12%), difference not significant. Risk factors for atherothrombotic brain infarction in elderly men were cigarette smoking (p less than 0.001), systolic or diastolic hypertension (p less than 0.001), and diabetes mellitus (p less than 0.005). Risk factors for atherothrombotic brain infarction in elderly women were systolic or diastolic hypertension (p less than 0.001), diabetes mellitus (p less than 0.001), and obesity (p less than 0.005).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3408020     DOI: 10.1177/000331978803900701

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  3 in total

1.  Serum lipids in young patients with ischaemic stroke: a case-control study.

Authors:  J F Albucher; J Ferrieres; J B Ruidavets; B Guiraud-Chaumeil; B P Perret; F Chollet
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

2.  Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study.

Authors:  E Lindenstrøm; G Boysen; J Nyboe
Journal:  BMJ       Date:  1994-07-02

3.  The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic review.

Authors:  Christopher Leonards; Martin Ebinger; Jana Batluk; Uwe Malzahn; Peter Heuschmann; Matthias Endres
Journal:  Front Neurol       Date:  2010-10-25       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.